Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatitis, Atopic | 24 | 2024 | 734 | 3.570 |
Why?
|
Food Hypersensitivity | 10 | 2024 | 737 | 2.740 |
Why?
|
Kaposi Varicelliform Eruption | 6 | 2016 | 47 | 2.170 |
Why?
|
Vaccinia virus | 7 | 2016 | 330 | 1.440 |
Why?
|
Ovalbumin | 17 | 2022 | 678 | 1.330 |
Why?
|
Allergens | 12 | 2024 | 1445 | 1.320 |
Why?
|
Skin | 19 | 2018 | 4520 | 1.160 |
Why?
|
Intermediate Filament Proteins | 5 | 2018 | 263 | 1.150 |
Why?
|
Interleukin-17 | 8 | 2018 | 923 | 0.890 |
Why?
|
Eosinophilic Esophagitis | 2 | 2016 | 204 | 0.820 |
Why?
|
Immune Tolerance | 3 | 2024 | 2326 | 0.770 |
Why?
|
Mice, Inbred BALB C | 21 | 2022 | 6241 | 0.770 |
Why?
|
Immunization | 7 | 2017 | 1220 | 0.720 |
Why?
|
TNF Receptor-Associated Factor 1 | 3 | 2008 | 48 | 0.650 |
Why?
|
Milk, Human | 2 | 2024 | 489 | 0.640 |
Why?
|
Maternal Exposure | 3 | 2024 | 1078 | 0.590 |
Why?
|
Eosinophilia | 1 | 2022 | 558 | 0.580 |
Why?
|
Antigen-Antibody Complex | 1 | 2017 | 511 | 0.510 |
Why?
|
Hypersensitivity | 3 | 2022 | 1172 | 0.490 |
Why?
|
Calpain | 1 | 2015 | 147 | 0.490 |
Why?
|
Cytokines | 9 | 2020 | 7449 | 0.470 |
Why?
|
Anaphylaxis | 3 | 2024 | 758 | 0.470 |
Why?
|
Immunoglobulin E | 4 | 2020 | 1510 | 0.450 |
Why?
|
Basophils | 1 | 2016 | 407 | 0.440 |
Why?
|
Neutrophil Infiltration | 2 | 2014 | 396 | 0.440 |
Why?
|
Mast Cells | 3 | 2020 | 1407 | 0.430 |
Why?
|
Immunoglobulins | 3 | 2016 | 856 | 0.430 |
Why?
|
Dermatitis | 2 | 2012 | 203 | 0.420 |
Why?
|
Disease Models, Animal | 16 | 2020 | 18388 | 0.390 |
Why?
|
Leukotriene C4 | 1 | 2012 | 79 | 0.390 |
Why?
|
Vaccinia | 1 | 2011 | 71 | 0.380 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2011 | 660 | 0.380 |
Why?
|
Receptors, Leukotriene | 1 | 2012 | 95 | 0.380 |
Why?
|
Leukotriene B4 | 1 | 2012 | 281 | 0.380 |
Why?
|
Th2 Cells | 5 | 2010 | 1079 | 0.370 |
Why?
|
Receptors, CCR4 | 1 | 2011 | 77 | 0.370 |
Why?
|
Smallpox Vaccine | 1 | 2011 | 77 | 0.370 |
Why?
|
Genome, Viral | 1 | 2015 | 673 | 0.360 |
Why?
|
Jejunum | 1 | 2013 | 475 | 0.360 |
Why?
|
Keratinocytes | 4 | 2018 | 879 | 0.360 |
Why?
|
Dermatitis, Allergic Contact | 2 | 2011 | 111 | 0.350 |
Why?
|
Langerhans Cells | 1 | 2010 | 169 | 0.340 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2024 | 2538 | 0.340 |
Why?
|
Animals | 42 | 2024 | 169418 | 0.340 |
Why?
|
Immunoglobulin G | 3 | 2017 | 4572 | 0.330 |
Why?
|
Interleukin-4 | 4 | 2016 | 1158 | 0.330 |
Why?
|
Mice | 34 | 2022 | 82045 | 0.330 |
Why?
|
Eosinophils | 3 | 2014 | 955 | 0.310 |
Why?
|
Virus Replication | 1 | 2016 | 2459 | 0.290 |
Why?
|
Adoptive Transfer | 6 | 2018 | 825 | 0.290 |
Why?
|
Interleukin-13 | 3 | 2016 | 392 | 0.280 |
Why?
|
Respiratory Hypersensitivity | 2 | 2009 | 272 | 0.280 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2009 | 977 | 0.280 |
Why?
|
Mice, Knockout | 17 | 2018 | 14480 | 0.270 |
Why?
|
Neutrophils | 5 | 2014 | 3790 | 0.230 |
Why?
|
Nose Neoplasms | 2 | 2003 | 250 | 0.230 |
Why?
|
Antigens | 4 | 2019 | 1443 | 0.220 |
Why?
|
Administration, Cutaneous | 4 | 2016 | 716 | 0.210 |
Why?
|
Azetidines | 1 | 2024 | 143 | 0.210 |
Why?
|
Leukemia, T-Cell | 1 | 2003 | 101 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1814 | 0.210 |
Why?
|
Lipopolysaccharides | 2 | 2008 | 2216 | 0.200 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2003 | 616 | 0.200 |
Why?
|
Dendritic Cells | 5 | 2017 | 2757 | 0.200 |
Why?
|
Detergents | 1 | 2022 | 235 | 0.190 |
Why?
|
Pneumonia | 3 | 2009 | 2162 | 0.190 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2003 | 354 | 0.180 |
Why?
|
Breast Feeding | 2 | 2019 | 1365 | 0.180 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2019 | 3108 | 0.180 |
Why?
|
Inflammation | 8 | 2022 | 10865 | 0.180 |
Why?
|
T-Lymphocytes | 7 | 2013 | 10273 | 0.170 |
Why?
|
Omeprazole | 1 | 2020 | 106 | 0.170 |
Why?
|
Cholera Toxin | 2 | 2013 | 562 | 0.170 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 618 | 0.160 |
Why?
|
Lung | 3 | 2009 | 10090 | 0.160 |
Why?
|
Leukocytes | 1 | 2007 | 2030 | 0.160 |
Why?
|
Interleukin-1alpha | 1 | 2018 | 86 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18048 | 0.150 |
Why?
|
Interferon-gamma | 3 | 2016 | 3169 | 0.150 |
Why?
|
Actins | 3 | 2014 | 2064 | 0.140 |
Why?
|
Receptors, Cytokine | 2 | 2016 | 257 | 0.140 |
Why?
|
Immunity, Mucosal | 1 | 2020 | 494 | 0.140 |
Why?
|
Mice, Transgenic | 6 | 2016 | 9558 | 0.140 |
Why?
|
Mice, Inbred C57BL | 7 | 2018 | 22365 | 0.140 |
Why?
|
Interleukins | 3 | 2018 | 792 | 0.140 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2016 | 30 | 0.130 |
Why?
|
Th1-Th2 Balance | 1 | 2016 | 38 | 0.130 |
Why?
|
Integrins | 2 | 2011 | 845 | 0.130 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 2 | 2014 | 163 | 0.130 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2014 | 259 | 0.120 |
Why?
|
Cell Polarity | 2 | 2016 | 639 | 0.120 |
Why?
|
Interleukin-23 | 1 | 2016 | 201 | 0.120 |
Why?
|
Carrier Proteins | 3 | 2014 | 4948 | 0.120 |
Why?
|
Pregnancy | 3 | 2024 | 30179 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 583 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 539 | 0.110 |
Why?
|
Infant, Newborn | 3 | 2024 | 26395 | 0.110 |
Why?
|
Signal Transduction | 4 | 2020 | 23638 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2016 | 12813 | 0.110 |
Why?
|
Enteropathogenic Escherichia coli | 1 | 2012 | 26 | 0.100 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 586 | 0.100 |
Why?
|
Hemolysin Proteins | 1 | 2012 | 113 | 0.100 |
Why?
|
Models, Animal | 1 | 2019 | 2126 | 0.100 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2012 | 83 | 0.100 |
Why?
|
Asthma | 2 | 2009 | 6274 | 0.100 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2012 | 93 | 0.100 |
Why?
|
GATA Transcription Factors | 1 | 2012 | 29 | 0.100 |
Why?
|
Killer Cells, Natural | 4 | 2013 | 2209 | 0.100 |
Why?
|
Th17 Cells | 1 | 2018 | 798 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4586 | 0.100 |
Why?
|
Adaptive Immunity | 2 | 2013 | 736 | 0.090 |
Why?
|
Humans | 24 | 2024 | 768451 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2017 | 1362 | 0.090 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2011 | 141 | 0.090 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2011 | 221 | 0.090 |
Why?
|
Receptors, Prostaglandin | 1 | 2010 | 53 | 0.090 |
Why?
|
Mice, Mutant Strains | 2 | 2018 | 1755 | 0.090 |
Why?
|
Dermis | 1 | 2012 | 204 | 0.090 |
Why?
|
Lymph Nodes | 4 | 2016 | 3472 | 0.090 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2011 | 196 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 607 | 0.090 |
Why?
|
Prostaglandin D2 | 1 | 2010 | 108 | 0.090 |
Why?
|
Sialoglycoproteins | 1 | 2011 | 320 | 0.090 |
Why?
|
Administration, Oral | 2 | 2024 | 4041 | 0.090 |
Why?
|
Esophagus | 1 | 2016 | 1045 | 0.090 |
Why?
|
Glutathione Transferase | 1 | 2012 | 567 | 0.080 |
Why?
|
Comorbidity | 1 | 2024 | 10601 | 0.080 |
Why?
|
Body Temperature | 1 | 2013 | 781 | 0.080 |
Why?
|
Receptors, Interleukin-21 | 1 | 2008 | 32 | 0.080 |
Why?
|
Female | 15 | 2024 | 396943 | 0.080 |
Why?
|
Interleukin-10 | 1 | 2013 | 1185 | 0.070 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 762 | 0.070 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1133 | 0.070 |
Why?
|
Cell Movement | 4 | 2016 | 5223 | 0.070 |
Why?
|
Inhalation | 1 | 2008 | 145 | 0.070 |
Why?
|
Herpesvirus 4, Human | 2 | 2003 | 1081 | 0.070 |
Why?
|
Bacterial Toxins | 1 | 2012 | 926 | 0.070 |
Why?
|
Permeability | 1 | 2009 | 725 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 257 | 0.060 |
Why?
|
Child, Preschool | 3 | 2024 | 42623 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4419 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1078 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11930 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 348 | 0.060 |
Why?
|
Fibrosis | 1 | 2012 | 2076 | 0.060 |
Why?
|
Antibodies | 1 | 2013 | 2425 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4728 | 0.060 |
Why?
|
Interleukin-2 | 2 | 2009 | 1894 | 0.060 |
Why?
|
Th1 Cells | 1 | 2009 | 1044 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2016 | 10494 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2010 | 1415 | 0.060 |
Why?
|
Skin Transplantation | 1 | 2009 | 1097 | 0.060 |
Why?
|
Hydroa Vacciniforme | 1 | 2003 | 2 | 0.060 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 2003 | 15 | 0.050 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2003 | 40 | 0.050 |
Why?
|
Collagen | 1 | 2012 | 2646 | 0.050 |
Why?
|
Gene Expression | 2 | 2015 | 7605 | 0.050 |
Why?
|
Vaccination | 1 | 2016 | 3434 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 89168 | 0.050 |
Why?
|
Chemokines | 1 | 2007 | 963 | 0.050 |
Why?
|
Cytoskeletal Proteins | 3 | 2014 | 1337 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1251 | 0.050 |
Why?
|
Cells, Cultured | 6 | 2020 | 19041 | 0.050 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2003 | 85 | 0.050 |
Why?
|
Receptors, CCR7 | 2 | 2014 | 106 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 295 | 0.050 |
Why?
|
Infant | 2 | 2024 | 36497 | 0.050 |
Why?
|
Genotype | 1 | 2015 | 13047 | 0.050 |
Why?
|
Purines | 1 | 2024 | 614 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1615 | 0.040 |
Why?
|
Biopsy | 1 | 2012 | 6816 | 0.040 |
Why?
|
Child | 3 | 2024 | 80863 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2568 | 0.040 |
Why?
|
Immunity, Innate | 2 | 2009 | 3080 | 0.040 |
Why?
|
Lymphoproliferative Disorders | 1 | 2003 | 531 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2007 | 2415 | 0.040 |
Why?
|
Phenotype | 2 | 2010 | 16712 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2020 | 277 | 0.040 |
Why?
|
DNA Primers | 1 | 2003 | 2826 | 0.040 |
Why?
|
Receptors, IgE | 1 | 2020 | 375 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2003 | 1139 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13655 | 0.040 |
Why?
|
Monocytes | 1 | 2007 | 2591 | 0.040 |
Why?
|
Incidence | 1 | 2015 | 21552 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 9623 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2882 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7599 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6135 | 0.030 |
Why?
|
Chemokine CCL19 | 1 | 2014 | 37 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1988 | 0.030 |
Why?
|
Cost of Illness | 1 | 2024 | 1960 | 0.030 |
Why?
|
Male | 6 | 2024 | 364781 | 0.030 |
Why?
|
Dermatitis, Contact | 1 | 2014 | 133 | 0.030 |
Why?
|
Polymerization | 1 | 2014 | 157 | 0.030 |
Why?
|
Population Surveillance | 1 | 2024 | 2601 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2024 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6091 | 0.030 |
Why?
|
Epidermis | 1 | 2016 | 539 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74915 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2014 | 423 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2012 | 11674 | 0.030 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2012 | 88 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2003 | 5904 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 457 | 0.030 |
Why?
|
Antigens, CD | 1 | 2003 | 4029 | 0.030 |
Why?
|
Spleen | 2 | 2008 | 2298 | 0.030 |
Why?
|
Base Sequence | 1 | 2003 | 12428 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3050 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2013 | 753 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 65409 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41797 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2005 | 5808 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2003 | 5152 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2014 | 729 | 0.020 |
Why?
|
Ligands | 1 | 2016 | 3281 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2010 | 302 | 0.020 |
Why?
|
Cell Line | 1 | 2003 | 15609 | 0.020 |
Why?
|
Interleukin-5 | 1 | 2009 | 267 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 692 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 1 | 2009 | 564 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3790 | 0.020 |
Why?
|
United States | 1 | 2015 | 73121 | 0.020 |
Why?
|
Cell Death | 1 | 2012 | 1684 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2016 | 2058 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 462 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2012 | 1461 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1170 | 0.010 |
Why?
|
Viral Load | 1 | 2013 | 3399 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2005 | 432 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2009 | 1179 | 0.010 |
Why?
|
Thymus Gland | 1 | 2009 | 1267 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3103 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1412 | 0.010 |
Why?
|
Genes, T-Cell Receptor | 1 | 2003 | 29 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2008 | 3594 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5801 | 0.010 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2003 | 158 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2003 | 370 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 2003 | 286 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2910 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4180 | 0.010 |
Why?
|
Viral Matrix Proteins | 1 | 2003 | 193 | 0.010 |
Why?
|
Genes, Viral | 1 | 2003 | 654 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1503 | 0.010 |
Why?
|
Lymphoma, T-Cell | 1 | 2003 | 304 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3735 | 0.010 |
Why?
|
Skin Diseases | 1 | 2009 | 1099 | 0.010 |
Why?
|
Clone Cells | 1 | 2003 | 1672 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5495 | 0.010 |
Why?
|
Adult | 3 | 2024 | 223542 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 1869 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60045 | 0.010 |
Why?
|
Cell Separation | 1 | 2003 | 1726 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2010 | 4781 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2005 | 2889 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5042 | 0.010 |
Why?
|
Viral Proteins | 1 | 2003 | 1803 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1669 | 0.010 |
Why?
|
Cell Lineage | 1 | 2003 | 2575 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 223418 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9505 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 9382 | 0.000 |
Why?
|